| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.18 | 0.002 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.097 | 0.002 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.15 | 0.003 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.77 | 0.003 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | 0.16 | 0.004 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.004 |